Patents by Inventor Garth Whiteside

Garth Whiteside has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9884059
    Abstract: Disclosed in certain embodiments is a method of treating or preventing an opioid-induced adverse pharmacodynamic response comprising administering to a patient in need thereof an effective amount of buprenorphine.
    Type: Grant
    Filed: March 26, 2015
    Date of Patent: February 6, 2018
    Assignee: Purdue Pharma L.P.
    Inventors: Michele Hummel, Donald J. Kyle, Garth Whiteside
  • Patent number: 9872856
    Abstract: Disclosed in certain embodiments is a method of treating or preventing an opioid-induced adverse pharmacodynamic response comprising administering to a patient in need thereof an effective amount of buprenorphine.
    Type: Grant
    Filed: February 3, 2015
    Date of Patent: January 23, 2018
    Assignee: Purdue Pharma L.P.
    Inventors: Michele Hummel, Donald J. Kyle, Garth Whiteside
  • Patent number: 9867817
    Abstract: Disclosed in certain embodiments is a method of treating or preventing an opioid-induced adverse pharmacodynamic response comprising administering to a patient in need thereof an effective amount of buprenorphine.
    Type: Grant
    Filed: March 26, 2015
    Date of Patent: January 16, 2018
    Assignee: Purdue Pharma L.P.
    Inventors: Michele Hummel, Donald J. Kyle, Garth Whiteside
  • Patent number: 9855262
    Abstract: Disclosed in certain embodiments is a method of treating or preventing an opioid-induced adverse pharmacodynamic response comprising administering to a patient in need thereof an effective amount of buprenorphine.
    Type: Grant
    Filed: March 26, 2015
    Date of Patent: January 2, 2018
    Assignee: Purdue Pharma L.P.
    Inventors: Michele Hummel, Donald J. Kyle, Garth Whiteside
  • Patent number: 9849124
    Abstract: Disclosed in certain embodiments is a method of treating or preventing an opioid induced adverse pharmacodynamic response comprising administering to a patient in need thereof an effective amount of buprenorphine.
    Type: Grant
    Filed: October 16, 2015
    Date of Patent: December 26, 2017
    Assignee: Purdue Pharma L.P.
    Inventors: Michele Hummel, Donald J. Kyle, Garth Whiteside
  • Publication number: 20170340646
    Abstract: Disclosed in certain embodiments is a method of decreasing gastric emptying comprising administering to a subject an effective amount of a sodium-channel blocker to decrease gastric emptying.
    Type: Application
    Filed: August 18, 2017
    Publication date: November 30, 2017
    Inventors: Michele Hummel, Donald J. Kyle, Garth Whiteside, Nathan Lautermilch
  • Patent number: 9763955
    Abstract: Disclosed in certain embodiments is a method of decreasing gastric emptying comprising administering to a subject an effective amount of a sodium-channel blocker to decrease gastric emptying.
    Type: Grant
    Filed: February 19, 2016
    Date of Patent: September 19, 2017
    Assignee: Purdue Pharma L.P.
    Inventors: Michele Hummel, Donald J. Kyle, Garth Whiteside, Nathan Lautermilch
  • Patent number: 9662326
    Abstract: Disclosed in certain embodiments is a method of treating or preventing an opioid-induced adverse pharmacodynamic response comprising administering to a patient in need thereof an effective amount of buprenorphine.
    Type: Grant
    Filed: February 26, 2015
    Date of Patent: May 30, 2017
    Assignee: Purdue Pharma L.P.
    Inventors: Michele Hummel, Donald J. Kyle, Garth Whiteside
  • Publication number: 20160243129
    Abstract: Disclosed in certain embodiments is a method of decreasing gastric emptying comprising administering to a subject an effective amount of a sodium-channel blocker to decrease gastric emptying.
    Type: Application
    Filed: February 19, 2016
    Publication date: August 25, 2016
    Inventors: Michele Hummel, Donald J. Kyle, Garth Whiteside, Nathan Lautermilch
  • Publication number: 20160106735
    Abstract: Disclosed in certain embodiments is a method of treating or preventing an opioid induced adverse pharmacodynamic response comprising administering to a patient in need thereof an effective amount of buprenorphine.
    Type: Application
    Filed: October 16, 2015
    Publication date: April 21, 2016
    Inventors: Michele Hummel, Donald J. Kyle, Garth Whiteside
  • Publication number: 20160074387
    Abstract: Disclosed in certain embodiments is a method of attenuating or preventing opioid-induced euphoria comprising administering to a patient in need thereof an effective amount of buprenorphine.
    Type: Application
    Filed: September 14, 2015
    Publication date: March 17, 2016
    Inventors: Michele Hummel, Donald J. Kyle, Garth Whiteside
  • Publication number: 20150216858
    Abstract: Disclosed in certain embodiments is a method of treating or preventing an opioid-induced adverse pharmacodynamic response comprising administering to a patient in need thereof an effective amount of buprenorphine.
    Type: Application
    Filed: February 3, 2015
    Publication date: August 6, 2015
    Inventors: Michelle Hummel, Donald J. Kyle, Garth Whiteside
  • Publication number: 20150196549
    Abstract: Disclosed in certain embodiments is a method of treating or preventing an opioid-induced adverse pharmacodynamic response comprising administering to a patient in need thereof an effective amount of buprenorphine.
    Type: Application
    Filed: March 26, 2015
    Publication date: July 16, 2015
    Inventors: Michele Hummel, Donald J. Kyle, Garth Whiteside
  • Publication number: 20150196551
    Abstract: Disclosed in certain embodiments is a method of treating or preventing an opioid-induced adverse pharmacodynamic response comprising administering to a patient in need thereof an effective amount of buprenorphine.
    Type: Application
    Filed: March 26, 2015
    Publication date: July 16, 2015
    Inventors: Michele Hummel, Donald J. Kyle, Garth Whiteside
  • Publication number: 20150196552
    Abstract: Disclosed in certain embodiments is a method of treating or preventing an opioid-induced adverse pharmacodynamic response comprising administering to a patient in need thereof an effective amount of buprenorphine.
    Type: Application
    Filed: March 26, 2015
    Publication date: July 16, 2015
    Inventors: Michele Hummel, Donald J. Kyle, Garth Whiteside
  • Publication number: 20150196548
    Abstract: Disclosed in certain embodiments is a method of treating or preventing an opioid-induced adverse pharmacodynamic response comprising administering to a patient in need thereof an effective amount of buprenorphine.
    Type: Application
    Filed: March 26, 2015
    Publication date: July 16, 2015
    Inventors: Michele Hummel, Donald J. Kyle, Garth Whiteside
  • Publication number: 20150196553
    Abstract: Disclosed in certain embodiments is a method of treating or preventing an opioid-induced adverse pharmacodynamic response comprising administering to a patient in need thereof an effective amount of buprenorphine.
    Type: Application
    Filed: March 26, 2015
    Publication date: July 16, 2015
    Inventors: Michele Hummel, Donald J. Kyle, Garth Whiteside
  • Publication number: 20150196554
    Abstract: Disclosed in certain embodiments is a method of treating or preventing an opioid-induced adverse pharmacodynamic response comprising administering to a patient in need thereof an effective amount of buprenorphine.
    Type: Application
    Filed: March 26, 2015
    Publication date: July 16, 2015
    Inventors: Michele Hummel, Donald J. Kyle, Garth Whiteside
  • Publication number: 20150164887
    Abstract: Disclosed in certain embodiments is a method of treating or preventing an opioid-induced adverse pharmacodynamic response comprising administering to a patient in need thereof an effective amount of buprenorphine.
    Type: Application
    Filed: February 26, 2015
    Publication date: June 18, 2015
    Inventors: Michele Hummel, Donald J. Kyle, Garth Whiteside
  • Publication number: 20150094326
    Abstract: Disclosed in certain embodiments is a method of treating or preventing an opioid-induced adverse pharmacodynamic response comprising administering to a patient in need thereof an effective amount of buprenorphine.
    Type: Application
    Filed: December 5, 2014
    Publication date: April 2, 2015
    Inventors: Michelle Hummel, Donald J. Kyle, Garth Whiteside